# Nicotine Polacrilex

NDC: 45802-089
Generic name: Nicotine Polacrilex
Labeler / Manufacturer: Padagis Israel Pharmaceuticals Ltd
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: LOZENGE
Routes: ORAL
Marketing started: 20160708

FDA application: ANDA203690

## Active ingredients

- NICOTINE: 2 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"45802-089"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=45802-089
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b765570e-e5b5-48e4-b4d2-2a85ac19a2ea